Home › Stocks › LFCR › All Fund Holders
LFCR — LIFECORE BIOMEDICAL INC · All Fund Holders
Funds holding (latest): 33 · Reported value held: $41.41M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 1.67M | $13.69M | 0.00% | Add |
| BlackRock Inc history | Q2 2026 | 2.01M | $10.57M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 855.50K | $4.49M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 769.36K | $4.04M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 253.82K | $1.33M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 177.47K | $931.72K | 0.00% | Add |
| Millennium Management history | Q2 2026 | 133.31K | $699.85K | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 124.94K | $655.93K | 0.00% | Reduce |
| Renaissance Technologies history | Q2 2026 | 104.86K | $550.51K | 0.00% | New |
| Citadel Advisors history | Q2 2026 | 98.87K | $519.07K | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 90.31K | $474.14K | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 87.65K | $460.16K | 0.00% | Add |
| Royce & Associates history | Q1 2024 | 75.61K | $401.49K | 0.00% | Hold |
| BNY Mellon history | Q2 2026 | 67.27K | $353.18K | 0.00% | Add |
| D. E. Shaw & Co history | Q4 2025 | 37.43K | $306.16K | 0.00% | New |
| AQR Capital Management history | Q2 2026 | 55.61K | $291.97K | 0.00% | Add |
| Point72 Asset Management history | Q2 2026 | 52.52K | $275.73K | 0.00% | Add |
| Two Sigma Investments history | Q4 2025 | 27.80K | $227.43K | 0.00% | New |
| Bank of America Corp history | Q2 2026 | 37.21K | $195.36K | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 26.10K | $137.01K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 23.81K | $124.98K | 0.00% | Add |
| Balyasny Asset Management history | Q3 2025 | 13.70K | $100.83K | 0.00% | Add |
| Arrowstreet Capital history | Q3 2021 | 10.01K | $92.00K | 0.00% | New |
| Prudential Financial history | Q1 2025 | 12.82K | $90.28K | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 16.54K | $86.81K | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 16.86K | $83.64K | 0.00% | New |
| Manulife Financial history | Q3 2025 | 10.04K | $73.89K | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 13.95K | $73.22K | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 10.10K | $53.03K | 0.00% | Add |
| Legal & General Investment Management America history | Q2 2026 | 2.40K | $12.61K | 0.00% | Hold |
| PNC Financial Services history | Q2 2026 | 2.06K | $10.81K | 0.00% | Add |
| T. Rowe Price Associates history | Q2 2026 | 22.56K | $119 | 0.00% | Add |
| Lazard Asset Management history | Q3 2024 | 277 | $1 | 0.00% | New |